- Home
- WGRX vs ANIK Comparison
WGRX vs ANIK Comparison
Compare WGRX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGRX
- ANIK
- Stock Information
- Founded
- WGRX 2022
- ANIK 1983
- Country
- WGRX United States
- ANIK United States
- Employees
- WGRX N/A
- ANIK N/A
- Industry
- WGRX Other Pharmaceuticals
- ANIK Medical/Dental Instruments
- Sector
- WGRX Health Care
- ANIK Health Care
- Exchange
- WGRX Nasdaq
- ANIK Nasdaq
- Market Cap
- WGRX 111.0M
- ANIK 133.1M
- IPO Year
- WGRX 2025
- ANIK 1993
- Fundamental
- Price
- WGRX $0.68
- ANIK $9.07
- Analyst Decision
- WGRX
- ANIK Buy
- Analyst Count
- WGRX 0
- ANIK 1
- Target Price
- WGRX N/A
- ANIK $15.00
- AVG Volume (30 Days)
- WGRX 1.3M
- ANIK 110.5K
- Earning Date
- WGRX 11-11-2025
- ANIK 10-30-2025
- Dividend Yield
- WGRX N/A
- ANIK N/A
- EPS Growth
- WGRX N/A
- ANIK N/A
- EPS
- WGRX N/A
- ANIK N/A
- Revenue
- WGRX $36,738,599.00
- ANIK $114,548,000.00
- Revenue This Year
- WGRX N/A
- ANIK N/A
- Revenue Next Year
- WGRX N/A
- ANIK $5.34
- P/E Ratio
- WGRX N/A
- ANIK N/A
- Revenue Growth
- WGRX 82384.51
- ANIK 16.52
- 52 Week Low
- WGRX $0.62
- ANIK $7.87
- 52 Week High
- WGRX $7.04
- ANIK $25.65
- Technical
- Relative Strength Index (RSI)
- WGRX N/A
- ANIK 50.02
- Support Level
- WGRX N/A
- ANIK $8.92
- Resistance Level
- WGRX N/A
- ANIK $9.58
- Average True Range (ATR)
- WGRX 0.00
- ANIK 0.37
- MACD
- WGRX 0.00
- ANIK 0.04
- Stochastic Oscillator
- WGRX 0.00
- ANIK 50.00
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.